HC Wainwright restated their buy rating on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $47.00 price objective on the stock. HC Wainwright also issued estimates for Tempest Therapeutics’ Q1 2024 earnings at ($0.36) EPS, Q2 2024 earnings at ($0.36) […]
Tempest Therapeutics (NASDAQ:TPST) Receives Outperform Rating from William Blair themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Free Report)’s share price traded down 4.9% on Thursday . The stock traded as low as $3.41 and last traded at $3.50. 488,163 shares were traded during trading, a decline of 31% from the average session volume of 710,658 shares. The stock had previously closed at $3.68. Analyst Upgrades […]
Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Free Report) traded down 4.9% on Thursday . The stock traded as low as $3.41 and last traded at $3.50. 488,163 shares changed hands during trading, a decline of 31% from the average session volume of 710,658 shares. The stock had previously closed at $3.68. Analyst Ratings Changes Separately, […]
Tempest Therapeutics, Inc (NASDAQ:TPST) Sees Significant Growth in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.